Concerns raised about medicaid drug rebates to states

被引:0
|
作者
不详
机构
关键词
D O I
10.1053/j.gastro.2005.07.051
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:781 / 782
页数:2
相关论文
共 50 条
  • [21] Drug Prices, Rebates, and Discounts
    Anderson-Cook, Anna
    Noda, Andrea
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (04): : 398 - +
  • [22] Number Of Medicaid Prescriptions Grew, Drug Spending Was Steady In Medicaid Expansion States
    Wen, Hefei
    Borders, Tyrone F.
    Druss, Benjamin G.
    HEALTH AFFAIRS, 2016, 35 (09) : 1604 - 1607
  • [23] Medicaid Expenditures and Estimated Rebates for Epinephrine Autoinjectors, 2012 to 2016
    Luo, Jing
    Kesselheim, Aaron S.
    Avorn, Jerry
    JAMA INTERNAL MEDICINE, 2017, 177 (05) : 734 - 736
  • [25] Concerns about average wholesale price-based reimbursement raised again
    不详
    ONCOLOGY-NEW YORK, 2001, 15 (11): : 1369 - 1369
  • [26] Concerns raised about Botswana's proposed HIV-disclosure law
    Ahmad, K
    LANCET, 2000, 356 (9230): : 662 - 662
  • [27] How Similar Are States' Medicaid Preferred Drug Lists?
    Ketcham, Jonathan D.
    Ngai, Jeffrey K.
    AMERICAN JOURNAL OF MANAGED CARE, 2008, 14 (11): : SP46 - SP52
  • [28] AstraZeneca receives double drug setback - Concerns raised over Iressa and Exanta
    不详
    TCE, 2004, (760): : 6 - 6
  • [29] MEDICARE AND MEDICAID - CUTS AND CONCERNS
    COLLINS, JA
    GERIATRICS, 1982, 37 (01) : 33 - &
  • [30] CONCERNS RAISED BY ALTERNATIVE CERTIFICATION
    DESCAMPS, JA
    KLINGSTEDT, JL
    EDUCATION, 1985, 105 (03): : 258 - 260